| 1 |
陈国标，杜 巍，周建平，等. 肺癌病例分布及病理特征趋势分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(5): 590-592.
|
| 2 |
张红军，房延凤，谢永宏，等. 肺癌患者异常糖链糖蛋白与传统肿瘤标志物的相关性分析[J/CD]. 中华肺部疾病杂志，2019, 12(1): 24-27.
|
| 3 |
Ruiz-Cordero R, Devine WP. Targeted therapy and checkpoint immunotherapy in lung cancer[J]. Surg Pathol Clin, 2020, 13(1): 17-33.
|
| 4 |
方美丹，郑 群，袁 远. 载脂蛋白A1与脂蛋白a在肺癌患者中的诊断价值[J]. 中国卫生检验杂志，2022, 32(1): 19-22, 45.
|
| 5 |
饶 汕，李 森. 肺癌患者中血清NSE、ProGRP、SAA的表达及与临床病理特征的关系[J]. 检验医学与临床，2022, 19(4): 463-466.
|
| 6 |
Fukuda Y, Fukuda N, Morishita S, et al. A novel doppler echocardiographic score reflecting cardiac functional status can predict adverse outcome in acute myocardial infarction[J]. J Echocardiogr, 2012, 10(2): 41-47.
|
| 7 |
Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer[J]. Lung, 2020, 198(6): 897-907.
|
| 8 |
魏建莹，孙 巍，刘晓民，等. TACE联合RFA治疗前血清ApoA1水平对肝细胞癌预后的影响[J]. 胃肠病学和肝病学杂志，2020, 29(1): 22-26.
|
| 9 |
Refaee T, Wu G, Ibrahim A, et al. The Emerging role of radiomics in copd and lung cancer[J]. Respiration, 2020, 99(2): 99-107.
|
| 10 |
Chen KN. The diagnosis and treatment of lung cancer presented as ground-glass nodule[J]. Gen Thorac Cardiovasc Surg, 2020, 68(7):697-702.
|
| 11 |
Toumazis I, Bastani M, Han SS, et al. Risk-based lung cancer screening: a systematic review[J]. Lung Cancer, 2020, 147(65): 154-186.
|
| 12 |
Oudkerk M, Liu S, Heuvelmans MA, et al. Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives[J]. Nat Rev Clin Oncol, 2021, 18(3): 135-151.
|
| 13 |
Thakur SK, Singh DP, Choudhary J. Lung cancer identification: a review on detection and classification[J]. Cancer Metastasis Rev, 2020, 39(3): 989-998.
|
| 14 |
Upadhya P, Ananthraju A, Vadala R, et al. Endocrine paraneoplastic syndromes in lung cancer: a respiratory physician′s perspective[J]. Adv Respir Med, 2021, 89(4): 403-412.
|
| 15 |
Vinod SK, Hau E. Radiotherapy treatment for lung cancer: current status and future directions[J]. Respirology, 2020, Suppl 2: 61-71.
|
| 16 |
张孝钦，陈玄一，邬盛昌. 循环肿瘤细胞在晚期非小细胞肺癌化疗疗效监测及预后预测中的价值研究[J]. 中国全科医学，2020, 23(2): 183-188.
|
| 17 |
Sangaletti S, Ferrara R, Tripodo C, et al. Myeloid cell heterogeneity in lung cancer: implication for immunotherapy[J]. Cancer Immunol Immunother, 2021, 70(9): 2429-2438.
|
| 18 |
Zhou F, Qiao M, Zhou C. The cutting-edge progress of immune-checkpoint blockade in lung cancer [J]. Cell Mol Immunol, 2021, 18(2): 279-293.
|
| 19 |
Wang Y, Zou S, Zhao Z, et al. New insights into small-cell lung cancer development and therapy[J]. Cell Biol Int, 2020, 44(8): 1564-1576.
|
| 20 |
Linehan A, Forde PM. Moving immunotherapy into early-stage lung cancer[J]. Cancer J, 2020, 26(6): 543-547.
|
| 21 |
Delk SC, Chattopadhyay A, Escola-Gil JC, et al. Apolipoprotein mimetics in cancer[J]. Semin Cancer Biol, 2021, 73(45): 158-168.
|
| 22 |
杨 静，周 虹，杨 航，等. 载脂蛋白A-1、D-二聚体对转移性胃肠道癌临床预后的预测价值[J]. 皖南医学院学报，2021, 40(4): 340-344.
|
| 23 |
Nishiyama H, Funamizu T, Iwata H, et al. Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up study[J]. Int J Cancer, 2022, 151(9): 1482-1490.
|
| 24 |
Halvorsen TG, Levernæs MCS, Rosting C. Matrix-assisted ionization and tandem mass spectrometry capabilities in protein biomarker characterization-an initial study using the small cell lung cancer biomarker progastrin releasing peptide as a model compound [J]. J Am Soc Mass Spectrom, 2021, 32(2): 611-614.
|
| 25 |
吴淑贞，宋慧敏，徐宏蕊，等. 糖类抗原125、胃泌素释放肽前体在小细胞肺癌诊断及预后评价中的作用[J]. 实用医院临床杂志，2022, 19(2): 5-8.
|
| 26 |
鲁 华，王 慧，曹玉萍. 血清鳞状细胞癌抗原、胃泌素释放肽前体在肺癌中的表达及对肺癌的诊断价值[J]. 癌症进展，2021, 19(15): 1585-1588.
|
| 27 |
Pedersen KM, Çolak Y, Bojesen SE, et al. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116，728 individuals[J]. J Hematol Oncol, 2020, 13(1): 129-132.
|
| 28 |
van der Vorst EPC. High-density lipoproteins and apolipoprotein A1[J]. Subcell Biochem, 2020, 94(25): 399-420.
|
| 29 |
方 黎，李 伟. 肺癌患者血清中CYFRA21-1、TIMP-1、ProGRP的表达水平及其与病理特征的关系[J]. 实用癌症杂志，2022, 37(4): 543-546,576.
|
| 30 |
卢丽君，喻长法，叶丽君，等. 鳞状细胞癌相关抗原、胃泌素释放肽前体、细胞角蛋白片段19和组织多肽特异性抗原联合检测在肺癌诊断中的应用[J]. 中国卫生检验杂志，2020, 30(12): 1458-1460.
|